This topic contains a solution. Click here to go to the answer

Author Question: Which of the following output levels would not be a valid LOW for a TTL gate? A) 0.2 V B) 0.5 V ... (Read 27 times)

shofmannx20

  • Hero Member
  • *****
  • Posts: 562
Which of the following output levels would not be a valid LOW for a TTL gate?
 
  A) 0.2 V B) 0.5 V C) 0.3 V D) All are valid.

Question 2

The binary equivalent of hexadecimal 2E is ________.
 
  A) 110001110 B) 00110111 C) 00100111 D) 00101110



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

ryrychapman11

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

D

Answer to Question 2

D




shofmannx20

  • Member
  • Posts: 562
Reply 2 on: Jul 28, 2018
Thanks for the timely response, appreciate it


LegendaryAnswers

  • Member
  • Posts: 341
Reply 3 on: Yesterday
Gracias!

 

Did you know?

For about 100 years, scientists thought that peptic ulcers were caused by stress, spicy food, and alcohol. Later, researchers added stomach acid to the list of causes and began treating ulcers with antacids. Now it is known that peptic ulcers are predominantly caused by Helicobacter pylori, a spiral-shaped bacterium that normally exist in the stomach.

Did you know?

In 1835 it was discovered that a disease of silkworms known as muscardine could be transferred from one silkworm to another, and was caused by a fungus.

Did you know?

In Eastern Europe and Russia, interferon is administered intranasally in varied doses for the common cold and influenza. It is claimed that this treatment can lower the risk of infection by as much as 60–70%.

Did you know?

Ether was used widely for surgeries but became less popular because of its flammability and its tendency to cause vomiting. In England, it was quickly replaced by chloroform, but this agent caused many deaths and lost popularity.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library